US FDA Designates Pyc`S Lead As A Fast Track Development Program
11 Aug 2023 //
PR NEWSWIRE
PYC Therapeutics Announces Comprehensive Preclinical Results for VP-002
29 Jun 2021 //
PRNEWSWIRE
PYC Therapeutics Announces Two Poster Presentations at (ARVO) 2021
04 May 2021 //
BIOSPACE
PYC Therapeutics Highlights Continued Progress of Ocular and CNS Pipeline
30 Apr 2021 //
BIOSPACE